These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12480702)

  • 1. Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass.
    Chandler WL; Velan T
    Blood; 2003 Jun; 101(11):4355-62. PubMed ID: 12480702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
    Dietrich W
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin generation and D-dimer formation during cardiopulmonary bypass.
    Chandler WL; Velan T
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):583-91. PubMed ID: 15389126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to reduce hemostatic activation during cardiopulmonary bypass.
    Eisses MJ; Velan T; Aldea GS; Chandler WL
    Thromb Res; 2006; 117(6):689-703. PubMed ID: 15996721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of surgical trauma and cardiopulmonary bypass on active thrombin concentrations and the rate of thrombin inhibition in vivo.
    Velan T; Chandler WL
    Pathophysiol Haemost Thromb; 2003; 33(3):144-56. PubMed ID: 15170395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reduction of prothrombin conversion by cardiac surgery with cardiopulmonary bypass shifts the haemostatic balance towards bleeding.
    Kremers RM; Bosch YP; Bloemen S; de Laat B; Weerwind PW; Mochtar B; Maessen JG; Wagenvoord RJ; Al Dieri R; Hemker HC
    Thromb Haemost; 2016 Aug; 116(3):442-51. PubMed ID: 27121983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.
    Knudsen L; Hasenkam JM; Kure HH; Hughes P; Bellaiche L; Ahlburg P; Djurhuus C
    Thromb Res; 1996 Oct; 84(1):45-54. PubMed ID: 8885146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ; Ofosu FA; Buchanan MR
    Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
    Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
    Eisses MJ; Seidel K; Aldea GS; Chandler WL
    Anesth Analg; 2004 May; 98(5):1208-16, table of contents. PubMed ID: 15105189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
    Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
    Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass.
    Chandler WL
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):459-67. PubMed ID: 16085250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
    Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
    Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiopulmonary bypass pumps and thrombin generation: what goes around comes around.
    Brister SJ; Pelletier A; Fedorshyn J; Puchalski S; Buchanan MR
    ASAIO J; 1998; 44(6):794-8. PubMed ID: 9831087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cardiopulmonary bypass on thrombin generation and protein C pathway.
    Taneja R; Liaw PL; Al Ghazaly S; Priestap F; Murkin JM; Martin CM
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):35-40. PubMed ID: 23312776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1.
    Kozek-Langenecker SA; Wanzel O; Berger R; Kettner SC; Coraim F
    Anesth Analg; 1998 Nov; 87(5):985-8. PubMed ID: 9806669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits.
    Ernofsson M; Thelin S; Siegbahn A
    Scand J Thorac Cardiovasc Surg; 1995; 29(4):157-65. PubMed ID: 8789468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.